CG Asset Management’s Pfizer PFE Stock Holding History

CG Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$726K	Sell	23,573 -23,148	-50%	-$707K	0.27%	90
2016 Q3	$1.5M	Buy	46,721 +20,975	+81%	+$701K	0.56%	52
2016 Q2	$860K	Buy	25,746 +527	+2%	+$16.8K	0.35%	75
2016 Q1	$709K	Sell	25,219 -5,059	-17%	-$145K	0.28%	77
2015 Q4	$927K	Buy	30,278 +4,917	+19%	+$155K	0.37%	69
2015 Q3	$756K	Sell	25,361 -3,642	-13%	-$117K	0.32%	72
2015 Q2	$923K	Buy	29,003 +20,674	+248%	+$674K	0.35%	73
2015 Q1	$275K	Buy	+8,329	New	+$265K	0.11%	104
2014 Q3	–	Sell	-7,471	Closed	-$210K	–	136
2014 Q2	$210K	Sell	7,471 -11,658	-61%	-$332K	0.09%	126
2014 Q1	$583K	Buy	19,129 +2,262	+13%	+$67.4K	0.26%	85
2013 Q4	$490K	Buy	+16,867	New	+$491K	0.22%	97

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CG Asset Management's PFE Position: Q4 2016 in Review

CG Asset Management reduced its Pfizer (PFE) stake by 50% in Q4 2016, selling an estimated $707K and leaving 23,573 shares worth $726K. The position accounts for 0.27% of the portfolio, ranked #90.

CG Asset Management first reported a position in PFE in Q4 2013 and has held it in 11 quarters since. The position peaked at $1.5M in Q3 2016. 2,059 funds tracked by Wall St. Rank hold PFE as of Q4 2016.

CG Asset Management held 23,573 shares of Pfizer worth $726K as of Q4 2016.
CG Asset Management sold 23,148 Pfizer shares in Q4 2016, an estimated $707K.
Pfizer made up 0.27% of CG Asset Management's portfolio in Q4 2016, its #90 holding.
CG Asset Management first reported a position in Pfizer in Q4 2013 and has held it in 11 quarters since.
CG Asset Management's Pfizer position peaked at $1.5M in Q3 2016.
2,059 funds tracked by Wall St. Rank held Pfizer as of Q4 2016.

Based on CG Asset Management's 13F filing for Q4 2016, filed 10 Feb 2017.